Results 171 to 180 of about 5,730 (206)

Simeprevir

Reactions Weekly, 2016
  +4 more sources

Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice

International Journal of Antimicrobial Agents, 2022
Jin He, Wei Hongping, Hang Yang
exaly  

Simeprevir/sofosbuvir

Reactions Weekly, 2017
  +5 more sources

Application of different spectrophotometric methods for quantitative analysis of direct acting antiviral drugs simeprevir and sofosbuvir

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2022
Sherif Ramzy
exaly  

Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA

Applied Microbiology and Biotechnology, 2022
Pengfei She, Zubair Hussain, Yong Wu
exaly  

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Lancet, The, 2014
Eric Lawitz, Mark S Sulkowski, Zobair M Younossi   +2 more
exaly  

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2014
Michael Manns, Maria Buti, Ewa Janczewska   +2 more
exaly  

Simeprevir

2018
openaire   +1 more source

Simeprevir

Reactions Weekly, 2014
openaire   +1 more source

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Lancet, The, 2014
Gregory J Dore, Graham R Foster, Michael W Fried   +2 more
exaly